Collateral for a security interest recorded Jun 7, 2024 (U.S. Bank Trust Company, National Association).
Term ended Sep 27, 2026 · High confidence
20-year base term ended Sep 27, 2026
Held by Biotissue Holdings Inc.
Filed Mar 13, 2013 as application 13/802,264 · Granted Dec 1, 2015
Base term plus 131 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
Term ended Sep 27, 2026
2006
2026
Clock starts
Sep 27, 2006
Sep 27, 2006
Term ended
Sep 27, 2026
Sep 27, 2026
Granted
Dec 1, 2015
Dec 1, 2015
base term
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
131
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,153,162, US 8,460,714.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 131 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 27, 2006, when application 11/528,980, the earliest non-provisional in its chain, was filed (this one was filed Mar 13, 2013) | Sep 27, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +131 days, USPTO patent term adjustment record | Feb 5, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,153,162, US 8,460,714) | capped to Sep 27, 2026 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Sep 27, 2026 | High confidence |
This family
| US 8,153,162 | In force May 2027 | May 2027 |
| US 8,460,714 | Term ended Sep 2026 | Sep 2026 |
| US 9,198,939 | this patent Sep 2026 | Sep 2026 |
| US 9,956,252 | Term ended Sep 2026 | Sep 2026 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 16, 2013 Reel 30227, frame 580 | Tseng, Scheffer; He, Hua; Li, Wei | Bio-Tissue, Inc. | Assignment of Assignor's Interest |
| Apr 16, 2013 Reel 30227, frame 611 | Bio-Tissue, Inc. | Tissue Tech, Inc. | Assignment of Assignor's Interest |
| Sep 1, 2015 Reel 36517, frame 55 | Bio-Tissue, Inc. | Tissuetech, Inc. | Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 030227 Frame: 0611. Assignor(S) Hereby Confirms the Assignment. |
| May 18, 2022 Reel 60116, frame 413 | Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc. | Midcap Financial Trust | Intellectual Property Security Agreement - Term Loan |
| May 18, 2022 Reel 60116, frame 468 | Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc. | Midcap Funding IV Trust | Intellectual Property Security Agreement - Revolving Loan |
| May 22, 2023 Reel 63713, frame 329 | Tissuetech, Inc. | Biotissue Holdings Inc. | Change of Name |
| Jun 7, 2024 reel/frame not recorded | Midcap Financial Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Financial Trust | Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Financial Trust | Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Funding IV Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Funding IV Trust | Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Funding IV Trust | Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
| Jun 7, 2024 Reel 67666, frame 235 | Biotissue Holdings Inc.; Biotissue Ocular Inc.; Biotissue Surgical Inc. | U.S. Bank Trust Company, National Association | Security Interest |
| Jun 7, 2024 Reel 67666, frame 165 | Midcap Financial Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
| Jun 7, 2024 Reel 67666, frame 200 | Midcap Funding IV Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 131 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,153,162, US 8,460,714.
Citations
25
later US patents cite this one
That is top 25% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.